INVEST: Individualised vocational support for youth with borderline personality disorder: A randomised controlled trial

Not Applicable

Recruiting

Conditions: Borderline personality disorder
Mental Health - Psychosis and personality disorders

Registration Number: ACTRN12619001220156

Lead Sponsor: Orygen, The National Centre of Excellence in Youth Mental Health

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: All

Target Recruitment: 88

Inclusion Criteria

1.All genders
2. Aged 15-25, inclusive
3.3 or more BPD criteria, as measured by SCID-5 PD
4.Desire to enter competitive employment and/or mainstream education
5.Sufficient fluency in English
6.Ability to provide informed consent and to adhere to study protocol

Exclusion Criteria

1.Inability to comply with informed consent procedure or study protocol
2.Participation in another trial which, in the opinion of the Investigator and/or clinical team, might confound the trial results or be too burdensome for the individual

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
IPS efficacy (vocational outcomes) as measured by number of days in mainstream/competitive education/employment. Number of days will be recorded via weekly text messages to participants (eg Thinking about the past 7 days, not including today, on how many days did you attend work or employment for which you were paid?). In addition, participants will be asked to estimate at each research assessment how many days have been spent in education and/or employment.[ Primary endpoint at 52 weeks from baseline assessment. Outcome measures will be assessed at research visits 13, 26, 39 and 52 weeks. Outcome will also be assessed weekly via text messages to each participant.]

Secondary Outcome Measures

Name	Time	Method
Cost effectiveness of IPS (composite secondary outcome) compared with UVS, measured using information from multiple sources, including Resource Use Questionnaire (RUQ), Medicare Benefits Scheme and Pharmaceutical Benefits Scheme data (MBS/PBS), welfare benefits as primary source of income, commencements of welfare benefits since baseline, intervention costs, quality adjusted life years (QALYs measured using AQoL-8D).[ Outcome measures will be assessed at research visits 0, 13, 26, 39 and 52 weeks.];Change in quality of life, as measured by Assessment of Quality of Life ( AQoL-8D)[ Outcome measures will be assessed at research visits 0, 13, 26, 39 and 52 weeks.];Change in BPD symptom severity (composite secondary outcome), as measured by the Borderline Personality Disorder Severity Index (BPDSI-IV) and Borderline Symptom List ( BSL-23)[ Outcome measures will be assessed at research visits 0, 13, 26, 39 and 52 weeks.]